NEONeoGenomics, Inc.

Healthcare

$16.35+92% 1Y

$16.35

$7.1952 weeks$19.90

Is it safe?

Watch

Solid, nothing alarming: clean books, but heavy debt (CCC) and big price swings.

1 good, 2 to watch, 2 neutral, 1 without data

Honest booksLow risk

Reported earnings show no manipulation flags Beneish M-score, a forensic model that detects earnings-manipulation patterns (receivables outrunning sales, margins slipping, accrual-heavy profit).

Quality4 / 9

Mixed fundamental signals Piotroski F-score, nine pass/fail tests of year-over-year financial health across profitability, balance sheet and efficiency. 7 to 9 is strong, 0 to 3 weak.

Insider conviction-$321K

Insiders were net sellers (-$321K, 90 days to Oct 8, 2026), selling is often routine.

Credit gradeCCCderived · Jun 30, 2026

Debt against weak or negative operating profit. A rule of thumb on leverage, not a credit rating.

Drawdown risk68% volderived · Oct 9, 2026

Large price swings, high volatility. Worst drawdown -92% · now 18% below its 52-week high.

Unless marked, from SEC EDGAR, as of Dec 31, 2025.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Volatilitybehind 84% of the market

Max drawdownbottom 9% of the market

Where this answer is blind. Altman sits structurally low for utilities and pipelines; Beneish runs high for fast growers, since sales growth alone lifts it; banks and REITs are excluded.

Can NEO take a bad year?

The deepest fall in NEO's price history on file is −92%; it is 18% below its high today.

$229M

Net debt · as at Q2 2026 · debt less the cash on hand, with no positive EBITDA to service it

Cash runway: 5+ years
Cash runway · burning $1.8M a quarter at the current rate
Annualised volatility: 68%
Annualised volatility · three times the market's own swing
Worst drawdown on file: −92%
Worst drawdown on file · −18% today